Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1145

1.

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells.

Tanaka A, Nishikawa H, Noguchi S, Sugiyama D, Morikawa H, Takeuchi Y, Ha D, Shigeta N, Kitawaki T, Maeda Y, Saito T, Shinohara Y, Kameoka Y, Iwaisako K, Monma F, Ohishi K, Karbach J, Jäger E, Sawada K, Katayama N, Takahashi N, Sakaguchi S.

J Exp Med. 2019 Nov 8. pii: jem.20191009. doi: 10.1084/jem.20191009. [Epub ahead of print]

PMID:
31704808
2.

The bacterial protein YidC accelerates MPIase-dependent integration of membrane proteins.

Sasaki M, Nishikawa H, Suzuki S, Moser M, Huber M, Sawasato K, Matsubayashi H, Kumazaki K, Tsukazaki T, Kuruma Y, Nureki O, Ueda T, Nishiyama KI.

J Biol Chem. 2019 Oct 29. pii: jbc.RA119.011248. doi: 10.1074/jbc.RA119.011248. [Epub ahead of print]

3.

Biosynthesis of bismuth selenide nanoparticles using chalcogen-metabolizing bacteria.

Kuroda M, Suda S, Sato M, Ayano H, Ohishi Y, Nishikawa H, Soda S, Ike M.

Appl Microbiol Biotechnol. 2019 Oct 23. doi: 10.1007/s00253-019-10160-2. [Epub ahead of print]

PMID:
31642950
4.

Association between Albumin-Bilirubin Grade and Non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.

Takata R, Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Sep 18;8(9). pii: E1485. doi: 10.3390/jcm8091485.

5.

Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids.

Tokunaga A, Sugiyama D, Maeda Y, Warner AB, Panageas KS, Ito S, Togashi Y, Sakai C, Wolchok JD, Nishikawa H.

J Exp Med. 2019 Sep 19. pii: jem.20190738. doi: 10.1084/jem.20190738. [Epub ahead of print]

PMID:
31537643
6.

Morphological Characteristics of Neuronal Death After Experimental Subarachnoid Hemorrhage in Mice Using Double Immunoenzymatic Technique.

Nakano F, Liu L, Kawakita F, Kanamaru H, Nakatsuka Y, Nishikawa H, Okada T, Shiba M, Suzuki H.

J Histochem Cytochem. 2019 Sep 17:22155419878181. doi: 10.1369/0022155419878181. [Epub ahead of print]

PMID:
31526082
7.

Biosynthesis of glycolipid MPIase (membrane protein integrase) is independent of the genes for ECA (enterobacterial common antigen).

Kamemoto Y, Funaba N, Kawakami M, Sawasato K, Kanno K, Suzuki S, Nishikawa H, Sato R, Nishiyama KI.

J Gen Appl Microbiol. 2019 Sep 10. doi: 10.2323/jgam.2019.05.001. [Epub ahead of print]

8.

Significant Correlation Between Grip Strength and m2bpgi in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Sep 1;8(9). pii: E1359. doi: 10.3390/jcm8091359.

9.

A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors.

Doi T, Muro K, Ishii H, Kato T, Tsushima T, Takenoyama M, Oizumi S, Gemmoto K, Suna H, Enokitani K, Kawakami T, Nishikawa H, Yamamoto N.

Clin Cancer Res. 2019 Aug 27. doi: 10.1158/1078-0432.CCR-19-1090. [Epub ahead of print]

PMID:
31455681
10.

A case report: stent implantation to treat coarctation of persistent 5th aortic arch associated with interrupted 4th aortic arch.

Kato A, Ohashi N, Nishikawa H.

Eur Heart J Case Rep. 2019 Jun 1;3(2). pii: ytz076. doi: 10.1093/ehjcr/ytz076.

11.

Toll-Like Receptor 4 and Tenascin-C Signaling in Cerebral Vasospasm and Brain Injuries After Subarachnoid Hemorrhage.

Suzuki H, Fujimoto M, Kawakita F, Liu L, Nakano F, Nishikawa H, Okada T, Imanaka-Yoshida K, Yoshida T, Shiba M.

Acta Neurochir Suppl. 2020;127:91-96. doi: 10.1007/978-3-030-04615-6_15. Review.

PMID:
31407069
12.

TAK-242, Toll-Like Receptor 4 Antagonist, Attenuates Brain Edema in Subarachnoid Hemorrhage Mice.

Okada T, Lei L, Nishikawa H, Nakano F, Nakatsuka Y, Suzuki H.

Acta Neurochir Suppl. 2020;127:77-81. doi: 10.1007/978-3-030-04615-6_13.

PMID:
31407067
13.

The Role of Galectin-3 in Subarachnoid Hemorrhage: A Preliminary Study.

Nishikawa H, Nakano F, Liu L, Nakatsuka Y, Okada T, Shiba M, Suzuki H.

Acta Neurochir Suppl. 2020;127:65-68. doi: 10.1007/978-3-030-04615-6_11.

PMID:
31407065
14.

Link Between Receptors That Engage in Developing Vasospasm After Subarachnoid Hemorrhage in Mice.

Nakano F, Kawakita F, Liu L, Nakatsuka Y, Nishikawa H, Okada T, Shiba M, Suzuki H.

Acta Neurochir Suppl. 2020;127:55-58. doi: 10.1007/978-3-030-04615-6_9.

PMID:
31407063
15.

Possible Involvement of Caspase-Independent Pathway in Neuronal Death After Subarachnoid Hemorrhage in Mice.

Nakano F, Liu L, Kawakita F, Nakatsuka Y, Nishikawa H, Okada T, Shiba M, Suzuki H.

Acta Neurochir Suppl. 2020;127:43-46. doi: 10.1007/978-3-030-04615-6_7.

PMID:
31407061
16.

The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan.

Kitano T, Nishikawa H, Suzuki R, Onaka M, Nishiyama A, Kitagawa D, Oka M, Masuo K, Yoshida S.

J Infect Chemother. 2019 Aug 2. pii: S1341-321X(19)30218-1. doi: 10.1016/j.jiac.2019.07.014. [Epub ahead of print]

PMID:
31383498
17.

Effect of Zn Addition on Interfacial Reactions and Mechanical Properties Between Eutectic Sn58Bi Solder and ENIG Substrate.

Zhou S, He S, Nishikawa H.

J Nanosci Nanotechnol. 2020 Jan 1;20(1):106-112. doi: 10.1166/jnn.2020.17268.

PMID:
31383144
18.
19.

Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.

Yamahara K, Hamada A, Soma T, Okamoto R, Okada M, Yoshihara S, Yoshihara K, Ikegame K, Tamaki H, Kaida K, Inoue T, Ohsugi Y, Nishikawa H, Hayashi H, Ito YM, Iijima H, Ohnishi S, Hashimoto D, Isoe T, Teshima T, Ogawa H, Sato N, Fujimori Y.

BMJ Open. 2019 Jul 9;9(7):e026403. doi: 10.1136/bmjopen-2018-026403.

20.

Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.

Tada T, Iijima H, Kobayashi N, Yoshida M, Nishimura T, Kumada T, Kondo R, Yano H, Kage M, Nakano C, Aoki T, Aizawa N, Ikeda N, Takashima T, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Nishikawa H, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Ultrasound Med Biol. 2019 Oct;45(10):2679-2687. doi: 10.1016/j.ultrasmedbio.2019.05.033. Epub 2019 Jul 3.

PMID:
31277922
21.

NNC 55-0396, a T-type calcium channel blocker, protects against the brain injury induced by middle cerebral artery occlusion and reperfusion in mice.

Matsuda S, Nishikawa H, Fukatsu A, Kurokawa Y, Tsubota M, Sekiguchi F, Tokuyama S, Kawabata A.

J Pharmacol Sci. 2019 Jun;140(2):193-196. doi: 10.1016/j.jphs.2019.02.002. Epub 2019 Feb 21.

22.

Predictors of disease progression after endoscopic sinus surgery in patients with chronic rhinosinusitis.

Tsuzuki K, Hashimoto K, Okazaki K, Nishikawa H, Sakagami M.

J Laryngol Otol. 2019 Aug;133(8):678-684. doi: 10.1017/S0022215119001245. Epub 2019 Jun 20.

PMID:
31218991
23.

Atropine-induced monomorphic ventricular tachycardia in an adolescent: A rare case.

Ohashi N, Nishikawa H, Yoshida S, Kato A, Morimoto Y, Yoshii K, Sato J.

J Cardiol Cases. 2018 Nov 13;19(2):51-54. doi: 10.1016/j.jccase.2018.10.003. eCollection 2019 Feb.

24.

Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Jun 1;8(6). pii: E782. doi: 10.3390/jcm8060782.

25.

Phaeohyphomycosis Due to Exophiala oligosperma in an Immunocompromised Host.

Nishikawa H, Taniguchi Y.

J Rheumatol. 2019 Jun;46(6):652. doi: 10.3899/jrheum.180774. No abstract available.

PMID:
31154445
26.

Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?

Ohue Y, Nishikawa H.

Cancer Sci. 2019 Jul;110(7):2080-2089. doi: 10.1111/cas.14069. Epub 2019 Jun 18. Review.

27.

Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies.

Datta M, Coussens LM, Nishikawa H, Hodi FS, Jain RK.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:165-174. doi: 10.1200/EDBK_237987. Epub 2019 May 17.

PMID:
31099649
28.

Association between High Platelet Reactivity Following Dual Antiplatelet Therapy and Ischemic Events in Japanese Patients with Coronary Artery Disease Undergoing Stent Implantation.

Nishikawa M, Takeda Y, Isomura N, Tanigawa T, Nanasato M, Tsukahara K, Kimura K, Takayama T, Hirayama A, Kato M, Nishikawa H, Nishimura Y, Isshiki T, Yokoi H; j-CHIPS group.

J Atheroscler Thromb. 2019 May 14. doi: 10.5551/jat.48934. [Epub ahead of print]

29.

Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity.

Tanegashima T, Togashi Y, Azuma K, Kawahara A, Ideguchi K, Sugiyama D, Kinoshita F, Akiba J, Kashiwagi E, Takeuchi A, Irie T, Tatsugami K, Hoshino T, Eto M, Nishikawa H.

Clin Cancer Res. 2019 Aug 1;25(15):4808-4819. doi: 10.1158/1078-0432.CCR-18-3991. Epub 2019 May 10.

PMID:
31076547
30.

Association between Sarcopenia and Depression in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 May 8;8(5). pii: E634. doi: 10.3390/jcm8050634.

31.

Increased seizure sensitivity, emotional defects and cognitive impairment in PHD finger protein 24 (Phf24)-null rats.

Serikawa T, Kunisawa N, Shimizu S, Kato M, Alves Iha H, Kinboshi M, Nishikawa H, Shirakawa Y, Voigt B, Nakanishi S, Kuramoto T, Kaneko T, Yamamoto T, Mashimo T, Sasa M, Ohno Y.

Behav Brain Res. 2019 Sep 2;369:111922. doi: 10.1016/j.bbr.2019.111922. Epub 2019 Apr 27.

PMID:
31039378
32.

PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.

Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara K, Sakaguchi S, Nishikawa H.

Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008. doi: 10.1073/pnas.1822001116. Epub 2019 Apr 26.

33.

Horizontal Boundary Cells, a Special Group of Somitic Cells, Play Crucial Roles in the Formation of Dorsoventral Compartments in Teleost Somite.

Abe K, Shimada A, Tayama S, Nishikawa H, Kaneko T, Tsuda S, Karaiwa A, Matsui T, Ishitani T, Takeda H.

Cell Rep. 2019 Apr 16;27(3):928-939.e4. doi: 10.1016/j.celrep.2019.03.068.

34.

Machine Learning Analysis of Matricellular Proteins and Clinical Variables for Early Prediction of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.

Tanioka S, Ishida F, Nakano F, Kawakita F, Kanamaru H, Nakatsuka Y, Nishikawa H, Suzuki H; pSEED group.

Mol Neurobiol. 2019 Oct;56(10):7128-7135. doi: 10.1007/s12035-019-1601-7. Epub 2019 Apr 13.

PMID:
30989629
35.

Importance of measurement of the diameter of the distal radial artery in a distal radial approach from the anatomical snuffbox before coronary catheterization.

Norimatsu K, Kusumoto T, Yoshimoto K, Tsukamoto M, Kuwano T, Nishikawa H, Matsumura T, Miura SI.

Heart Vessels. 2019 Oct;34(10):1615-1620. doi: 10.1007/s00380-019-01404-2. Epub 2019 Apr 10.

PMID:
30972548
36.

<Editors' Choice> Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.

Kochin V, Nishikawa H.

Nagoya J Med Sci. 2019 Feb;81(1):1-18. doi: 10.18999/nagjms.81.1.1. Review.

37.

7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial.

Shiomi H, Kozuma K, Morimoto T, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Takeji Y, Suwa S, Ito Y, Kobayashi M, Dai K, Nakao K, Tarutani Y, Taniguchi R, Nishikawa H, Yamamoto Y, Nakagawa Y, Ando K, Kobayashi K, Kawai K, Hibi K, Kimura T; RESET Investigators.

JACC Cardiovasc Interv. 2019 Apr 8;12(7):637-647. doi: 10.1016/j.jcin.2019.01.234.

PMID:
30947938
38.

[Cancer Immunoediting in the Development of Cancer Immunotherapy].

Ariyasu R, Nishikawa H.

Gan To Kagaku Ryoho. 2019 Mar;46(3):407-411. Japanese.

PMID:
30914573
39.
40.

Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases.

Nishimura T, Iijima H, Nishikawa H, Kondo R, Yano H, Kage M, Aoki T, Nakano C, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Takashima T, Aizawa N, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Hepatol Res. 2019 Jul;49(7):721-730. doi: 10.1111/hepr.13332. Epub 2019 May 2.

PMID:
30884015
41.

Craniofacial Approaches to Pediatric Orbital Tumors.

Kaderbhai J, Lo W, Rodrigues D, White N, Evans M, Nishikawa H, Dover MS.

J Craniofac Surg. 2019 Jun;30(4):1198-1200. doi: 10.1097/SCS.0000000000005265.

PMID:
30865111
42.

Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Mar 11;8(3). pii: E336. doi: 10.3390/jcm8030336.

43.

Effect of FeCoNiCrCu0.5 High-entropy-alloy Substrate on Sn Grain Size in Sn-3.0Ag-0.5Cu Solder.

Shen YA, Lin CM, Li J, He S, Nishikawa H.

Sci Rep. 2019 Mar 6;9(1):3658. doi: 10.1038/s41598-019-40268-4.

44.

A Computational Thermodynamics-Assisted Development of Sn-Bi-In-Ga Quaternary Alloys as Low-Temperature Pb-Free Solders.

Yang CH, Zhou S, Lin SK, Nishikawa H.

Materials (Basel). 2019 Feb 20;12(4). pii: E631. doi: 10.3390/ma12040631.

45.

Case report: Atrioventricular block after transcatheter atrial septal closure using the Figulla® Flex II ASD occluder.

Sato J, Kato A, Takeda S, Nishikawa H.

Catheter Cardiovasc Interv. 2019 Apr 1;93(5):E298-E301. doi: 10.1002/ccd.28148. Epub 2019 Feb 17.

PMID:
30773790
46.

[A Case of Gastric Small Cell Carcinoma with Rapid Regrowth after Surgery].

Watanabe M, Miyake T, Mikane Y, Syoji R, Kajiwara Y, Aoyama K, Nogami T, Nishikawa H, Shinoura S, Shigemitsu K, Nonaka Y, Hayashi D.

Gan To Kagaku Ryoho. 2019 Jan;46(1):145-147. Japanese.

PMID:
30765669
47.

ERF-related craniosynostosis: The phenotypic and developmental profile of a new craniosynostosis syndrome.

Glass GE, O'Hara J, Canham N, Cilliers D, Dunaway D, Fenwick AL, Jeelani NO, Johnson D, Lester T, Lord H, Morton JEV, Nishikawa H, Noons P, Schwiebert K, Shipster C, Taylor-Beadling A, Twigg SRF, Vasudevan P, Wall SA, Wilkie AOM, Wilson LC.

Am J Med Genet A. 2019 Apr;179(4):615-627. doi: 10.1002/ajmg.a.61073. Epub 2019 Feb 13.

48.

Scleral buckling versus vitrectomy for young japanese patients with rhegmatogenous retinal detachment in the era of microincision surgery: real-world evidence from a multicentre study in Japan.

Shu I, Ishikawa H, Nishikawa H, Morikawa S, Okamoto F, Sakamoto T, Sugimoto M, Kondo M, Iwasaki M, Kinoshita T, Toibana T, Mitamura Y, Takamura Y, Motohashi R, Shimura M, Sakurai Y, Takeuchi M, Gomi F.

Acta Ophthalmol. 2019 Aug;97(5):e736-e741. doi: 10.1111/aos.14050. Epub 2019 Feb 11.

PMID:
30741467
49.

CdsA is involved in biosynthesis of glycolipid MPIase essential for membrane protein integration in vivo.

Sawasato K, Sato R, Nishikawa H, Iimura N, Kamemoto Y, Fujikawa K, Yamaguchi T, Kuruma Y, Tamura Y, Endo T, Ueda T, Shimamoto K, Nishiyama KI.

Sci Rep. 2019 Feb 4;9(1):1372. doi: 10.1038/s41598-018-37809-8.

50.

Regulatory T cells in cancer immunosuppression - implications for anticancer therapy.

Togashi Y, Shitara K, Nishikawa H.

Nat Rev Clin Oncol. 2019 Jun;16(6):356-371. doi: 10.1038/s41571-019-0175-7. Review.

PMID:
30705439

Supplemental Content

Loading ...
Support Center